RHC+10%: was strong after the private hospital operator posted better-than-expected first-half earnings and profit as the performance of its core Australian hospitals business improved. However, the company said cuts to the National Health Service funding in the UK hurt earnings from its British business, while its European operations disappointed.
1H26 Highlights
- Net income $160.7 million vs. loss $104.9 million YoY.
- Total revenues & other income $9.38 billion, +9.3% YoY.
- Interim dividend per share $0.425.
- Ebitda from continuing operations $1.12 billion, +6.4% YoY.
Chief executive Natalie Davis said her transformation plan for Australia’s biggest private operator was progressing, with an improvement in hospital admissions, operating theatre utilisation, market share, revenue and margins.
- A solid result and with expectations low around this serial underperformer its was enough to produce the double digit gains.
MM is now bullish towards RHC around $42
Add To Hit List
